Patients as Partners U.S. Podcast Series
Patients as Partners U.S. has posted another installment in its podcast series highlighting last year's event. The series includes: Chief [...]
Blog Considers Cost of Flattening the Curve
A recent blog post on The Incidental Economist highlights the economic costs of the current shutdown spurred by COVID-19. The [...]
Evidera Blog Post Highlights Approach to Assessing Real-World Research Questions
A recent Evidera blog post highlights its systematic approach to the assessment of real-world research questions supported by digital enablement. [...]
Collecting Data in the Midst of a Pandemic
Evidera's Mariah Baltezegar in a recent blog post considers how to best collect data during the COVID-19 pandemic. Baltezegar writes [...]
Harvard Researchers Suggest Central Database to Fill Evidence Gaps
Harvard researchers in a recent article say a central database should be developed to help fill in precision medicine evidence [...]
Report Examines Potential of Real-World Clinicogenomic Data
A recent article published in Cancer Discovery considers the potential of real-world data on AKT1-mutant metastatic breast cancer. Researchers utilized [...]
Nexus 2020 Issues Call for Posters
The Academy of Managed Care Pharmacy (AMCP) is now accepting poster submissions as it gears up for the Nexus 2020 [...]
ICER: Remdesivir Cost-effective at $4,460
The Institute for Clinical and Economic Review (ICER) has established a starting point for discussion about the price of Gilead's [...]
Xcenda Blog: Mind the (Evidence) Gap
Xcenda in a blog post considers how drug manufacturers can gather evidence to develop their value story before and after [...]
HIPPA in the Wake of COVID-19
Primary care physician Dr. Ratul Chatterjee tells MedCity News it would be easier to handle EHR data without HIPAA restrictions [...]
How Can New Software Bolster HTA?
Panelists in an on-demand webinar discuss how new software can be utilized to improve health technology assessment. "The limits of [...]
Article Considers Precision Medicine in Value Frameworks
A recent article published in Value in Health considers how value assessments tackle precision medicine. Researchers found the lack of [...]
Hatswell Considers Impact of COVID-19 on Health Economics
In a recent editorial, Delta Hat's Anthony Hatswell considers the implications for the health economics landscape in the midst of [...]
Aetion, HealthVerity Launch RWE System
Aetion and HealthVerity last month launched a new real-world evidence system aimed at helping the assessment of treatment approaches for [...]
Public Citizen to Pharma: Stop Raising Prices During a Pandemic
Public Citizen in a recent campaign asked 20 pharmaceutical companies to halt price increases as the U.S. grapples with the [...]
Article Highlights FDA Decisions that Involved RWE
A recent article published on Aetion looks at three recent decisions by the Food and Drug Administration (FDA) that included [...]
PRMA Offers Tips on Working From Home
PRMA Consulting in a recent blog post offers six key tips for bolstering connectivity and productivity while working from home. [...]
Study: Value Assessments Should Factor Full Range of Costs, Benefits
A recent study published in JMCP suggests value assessments should capture the full range of costs and benefits associated with [...]
HEAL Accepting Applications for Online Programs
HEAL at Lancaster University is accepting applications for its online health economics and policy PhD and MSc programs. "Our programmes, [...]
Podcast Highlights COVID-19 Testing Coverage Woes
A recent installment of Kaiser Health News' "An Arm and a Leg" podcast dives into the story of one person's [...]
Study: Orphan Drugs Offer ‘Larger Health Gains’ Over Non-Orphan Drugs
A recent study led by Tufts CEVR's James Chambers suggests orphan drugs "offer larger health gains than non-orphan drugs." However, [...]
New Data Shows Part D Savings Took Hit Due to Price Increases on RA Drugs
A new study published in JAMA Network Open suggests patients took a big hit on savings for RA drugs under [...]
Blog: What do High Drug Prices Buy Us?
A recent Health Affairs blog post looks at what the U.S. is actually getting with such high drug prices. The [...]
Veradigm Platform Generates Actionable RWE
Veradigm in a recent analysis found that de-identified data from its EHR platform could be used to generate "actionable and [...]
Aetion Launches FDA Decision Alerts
Aetion announced the launch of a new library of FDA submissions that used real-world data and real-world evidence, the FDA [...]